Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis

ClinicalTrials.gov ID: NCT02864082

Public ClinicalTrials.gov record NCT02864082. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis

Study identification

NCT ID
NCT02864082
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Patagonia Pharmaceuticals, LLC
Industry
Enrollment
19 participants

Conditions and interventions

Interventions

  • PAT-001, 0.1% Drug
  • PAT-001, 0.2% Drug
  • Vehicle for PAT-001 0.1% Drug
  • Vehicle for PAT-001 0.2% Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 7, 2017
Primary completion
Feb 12, 2018
Completion
Dec 3, 2018
Last update posted
Sep 28, 2021

2017 – 2018

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
TCR Medical Corporation San Diego California 92123
Yale Center for Clinical Investigation New Haven Connecticut 06519
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
Paddington Testing Co., Inc Philadelphia Pennsylvania 19103
Texas Dermatology and Laser Specialists San Antonio Texas 78218

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02864082, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 28, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02864082 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →